News

MUSC initiative aims to increase human papillomavirus vaccination rates in underserved communities.

Adult and pediatric doctors pooled their expertise to ensure a young patient would have few physical reminders of an extraordinary lung cancer surgery.

Jezabel R. Blanco is determined to find better treatments for children with medulloblastoma.

The children's cancer team attained the best outcomes in the Southeast, according to recently released rankings.

MUSC researchers have developed a way to remove toxic chemotherapeutic drugs from the blood after cancer treatment to prevent them from reaching the heart.

Personal loss inspired a Hollings researcher to apply breast cancer findings toward a potential new osteosarcoma treatment.

MUSC Hollings Cancer Center researchers have secured important funding for trials to reduce vaping among adolescents.

Hollings is part of a national call to action to get HPV vaccination back on track for children and adolescents.

Hollings researcher Dr. Nancy Klauber-DeMore played a vital role in the FDA granting rare pediatric disease designation for a new osteosarcoma treatment.

The latest HPV vaccination survey shows that South Carolina's rates are on par with overall national rates for the first time.